Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185913 · ClinicalTrials.gov registry record
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 50
- Enrollment target
NCT00185913: Completed study, sponsored by Stanford University.
NCT00185913 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185913 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2000-09 |
| Est. Completion | 2008-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185913
The ClinicalTrials.gov registry entry for NCT00185913 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00185913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00185913 about?
NCT00185913 is a clinical study titled "Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers". The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
What is the current status of trial NCT00185913?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2000-09. Estimated completion is 2008-05.
Who is sponsoring clinical trial NCT00185913?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.